126 results
Page 2 of 7
8-K
EX-99.1
m1zji
11 May 23
Equillium Reports First Quarter 2023 Financial Results and Provides Clinical Updates
4:06pm
PRE 14A
ozoa1l
31 Mar 23
Preliminary proxy
4:02pm
425
eiiqhvri 0io4se7
14 Nov 22
Business combination disclosure
4:20pm
8-K
EX-99.1
sz1wmclgwb
14 Nov 22
Equillium Reports Third Quarter 2022 Financial Results and Provides Corporate and Clinical Updates
4:10pm
424B3
vtelitf8mom 7i
10 Nov 22
Prospectus supplement
4:13pm
S-4/A
ht281rf
9 Nov 22
Registration of securities issued in business combination transactions (amended)
4:31pm
S-4
ivopt
26 Oct 22
Registration of securities issued in business combination transactions
9:59pm
425
vlg 4uv8ij6uzf0
26 Sep 22
Business combination disclosure
5:29pm
8-K
EX-99.1
vfbqavks8b5w 5wb
26 Sep 22
Report of Independent Registered Public Accounting Firm
5:27pm
8-K
EX-99.2
teylojct
26 Sep 22
Report of Independent Registered Public Accounting Firm
5:27pm
425
ey52 9j4ls97n
6 Sep 22
Business combination disclosure
4:33pm
8-K
h2cbn
6 Sep 22
Equillium to Acquire Metacrine in All-Stock Transaction
4:29pm
8-K
EX-2.1
128p7q5x lo4v87
6 Sep 22
Equillium to Acquire Metacrine in All-Stock Transaction
4:29pm
8-K
EX-99.1
klwpyfk1
15 Aug 22
Equillium Reports Second Quarter 2022 Financial Results and Provides Clinical Development Updates
4:22pm
8-K
EX-99.1
zog 0j3lktli
12 May 22
Equillium Reports First Quarter 2022 Financial Results and Provides Corporate and Clinical Development Updates
4:07pm